- Investing Ideas
- German Pharmaceuticals & Biotech Profitable Climbers
German Pharmaceuticals & Biotech Profitable Climbers
Results
3
0 new
3 companies
Novogenia
Market Cap: €95.4m
Operates in the healthcare industry.
7V0
€7.95
7D
0%
1Y
10.4%
Cantourage Group
Market Cap: €77.3m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€6.20
7D
0.6%
1Y
20.6%
SynBiotic
Market Cap: €8.1m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€1.19
7D
13.3%
1Y
-61.9%